SION
Sionna Therapeutics, Inc.
Key Financials
Operating Income
$-88982000
↓ 26.1%
Total Assets
$326.0M
↑ 75.5%
Net Income
$-75268000
↓ 22.0%
EPS (Diluted)
$-1.88
↑ 88.2%
Shareholders' Equity
$306.8M
↑ 287.4%
Cash & Equivalents
$58.5M
↑ 54.7%
Total Liabilities
$19.1M
↑ 0.1%
Operating Cash Flow
$-66297000.00
↓ 25.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/16/2026 | View on SEC |
| 4 | 4/16/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
| 144 | 3/5/2026 | View on SEC |
| S-8 | 3/2/2026 | View on SEC |
| S-3ASR | 3/2/2026 | View on SEC |
| 10-K | 3/2/2026 | View on SEC |
| 8-K | 3/2/2026 | View on SEC |
| 4 | 2/4/2026 | View on SEC |
| 4 | 2/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SION |
| Company Name | Sionna Therapeutics, Inc. |
| CIK | 2036042 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-819-2020 |